Global Incretin-Based Drugs Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028

Detailed TOC of Global Incretin-Based Drugs Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028

Table of Content

1 Market Overview
1.1 Product Overview and Scope of Incretin-Based Drugs
1.1.1 Market Coverage
1.1.2 Market Definition
1.2 Market Analysis by Type
1.3 Market Analysis by Application
1.4 Market Analysis by Region
1.4.1 Global Incretin-Based Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2018-2023)
1.4.2 United States Incretin-Based Drugs Market Status and Prospect (2018-2023)
1.4.3 Europe Incretin-Based Drugs Market Status and Prospect (2018-2023)
1.4.4 China Incretin-Based Drugs Market Status and Prospect (2018-2023)
1.4.5 Japan Incretin-Based Drugs Market Status and Prospect (2018-2023)
1.4.6 India Incretin-Based Drugs Market Status and Prospect (2018-2023)
1.4.7 Southeast Asia Incretin-Based Drugs Market Status and Prospect (2018-2023)
1.4.8 Latin America Incretin-Based Drugs Market Status and Prospect (2018-2023)
1.4.9 Middle East and Africa Incretin-Based Drugs Market Status and Prospect (2018-2023)
1.5 Global Incretin-Based Drugs Market Size and Forecast
1.5.1 Global Incretin-Based Drugs Revenue ($) (2018-2028)
1.5.2 Global Incretin-Based Drugs Sales (2018-2028)
1.5.3 Global Incretin-Based Drugs Average Price (2018-2028)

2 Players Profiles
2.1 Intarcia Therapeutics
2.1.1 Intarcia Therapeutics Company Profiles
2.1.2 Intarcia Therapeutics Incretin-Based Drugs Product and Services
2.1.3 Intarcia Therapeutics Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.1.4 Intarcia Therapeutics Recent Developments/Updates
2.2 Emisphere Technologies
2.2.1 Emisphere Technologies Company Profiles
2.2.2 Emisphere Technologies Incretin-Based Drugs Product and Services
2.2.3 Emisphere Technologies Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.2.4 Emisphere Technologies Recent Developments/Updates
2.3 Chemocentryx
2.3.1 Chemocentryx Company Profiles
2.3.2 Chemocentryx Incretin-Based Drugs Product and Services
2.3.3 Chemocentryx Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.3.4 Chemocentryx Recent Developments/Updates
2.4 Novartis International
2.4.1 Novartis International Company Profiles
2.4.2 Novartis International Incretin-Based Drugs Product and Services
2.4.3 Novartis International Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.4.4 Novartis International Recent Developments/Updates
2.5 Glaxosmithkline
2.5.1 Glaxosmithkline Company Profiles
2.5.2 Glaxosmithkline Incretin-Based Drugs Product and Services
2.5.3 Glaxosmithkline Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.5.4 Glaxosmithkline Recent Developments/Updates
2.6 Cebix
2.6.1 Cebix Company Profiles
2.6.2 Cebix Incretin-Based Drugs Product and Services
2.6.3 Cebix Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.6.4 Cebix Recent Developments/Updates
2.7 LG Life Sciences
2.7.1 LG Life Sciences Company Profiles
2.7.2 LG Life Sciences Incretin-Based Drugs Product and Services
2.7.3 LG Life Sciences Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.7.4 LG Life Sciences Recent Developments/Updates
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Company Profiles
2.8.2 Johnson & Johnson Incretin-Based Drugs Product and Services
2.8.3 Johnson & Johnson Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.8.4 Johnson & Johnson Recent Developments/Updates
2.9 Boehringer Ingelheim
2.9.1 Boehringer Ingelheim Company Profiles
2.9.2 Boehringer Ingelheim Incretin-Based Drugs Product and Services
2.9.3 Boehringer Ingelheim Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.9.4 Boehringer Ingelheim Recent Developments/Updates
2.10 Furiex Pharmaceuticals
2.10.1 Furiex Pharmaceuticals Company Profiles
2.10.2 Furiex Pharmaceuticals Incretin-Based Drugs Product and Services
2.10.3 Furiex Pharmaceuticals Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.10.4 Furiex Pharmaceuticals Recent Developments/Updates
2.11 Arisaph
2.11.1 Arisaph Company Profiles
2.11.2 Arisaph Incretin-Based Drugs Product and Services
2.11.3 Arisaph Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.11.4 Arisaph Recent Developments/Updates
2.12 Becton
2.12.1 Becton Company Profiles
2.12.2 Becton Incretin-Based Drugs Product and Services
2.12.3 Becton Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.12.4 Becton Recent Developments/Updates
2.13 Bristol-Myers Squibb
2.13.1 Bristol-Myers Squibb Company Profiles
2.13.2 Bristol-Myers Squibb Incretin-Based Drugs Product and Services
2.13.3 Bristol-Myers Squibb Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.13.4 Bristol-Myers Squibb Recent Developments/Updates
2.14 Aerpio Therapeutics
2.14.1 Aerpio Therapeutics Company Profiles
2.14.2 Aerpio Therapeutics Incretin-Based Drugs Product and Services
2.14.3 Aerpio Therapeutics Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.14.4 Aerpio Therapeutics Recent Developments/Updates
2.15 Concert Pharmaceuticals
2.15.1 Concert Pharmaceuticals Company Profiles
2.15.2 Concert Pharmaceuticals Incretin-Based Drugs Product and Services
2.15.3 Concert Pharmaceuticals Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.15.4 Concert Pharmaceuticals Recent Developments/Updates
2.16 Kyorin Pharmaceutical
2.16.1 Kyorin Pharmaceutical Company Profiles
2.16.2 Kyorin Pharmaceutical Incretin-Based Drugs Product and Services
2.16.3 Kyorin Pharmaceutical Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.16.4 Kyorin Pharmaceutical Recent Developments/Updates
2.17 Eli Lilly
2.17.1 Eli Lilly Company Profiles
2.17.2 Eli Lilly Incretin-Based Drugs Product and Services
2.17.3 Eli Lilly Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.17.4 Eli Lilly Recent Developments/Updates
2.18 Novo Nordisk
2.18.1 Novo Nordisk Company Profiles
2.18.2 Novo Nordisk Incretin-Based Drugs Product and Services
2.18.3 Novo Nordisk Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.18.4 Novo Nordisk Recent Developments/Updates
2.19 Dong-A Socio Holdings
2.19.1 Dong-A Socio Holdings Company Profiles
2.19.2 Dong-A Socio Holdings Incretin-Based Drugs Product and Services
2.19.3 Dong-A Socio Holdings Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.19.4 Dong-A Socio Holdings Recent Developments/Updates
2.20 Dipexium Pharmaceuticals
2.20.1 Dipexium Pharmaceuticals Company Profiles
2.20.2 Dipexium Pharmaceuticals Incretin-Based Drugs Product and Services
2.20.3 Dipexium Pharmaceuticals Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.20.4 Dipexium Pharmaceuticals Recent Developments/Updates
2.21 Kyowa Hakko Kirin
2.21.1 Kyowa Hakko Kirin Company Profiles
2.21.2 Kyowa Hakko Kirin Incretin-Based Drugs Product and Services
2.21.3 Kyowa Hakko Kirin Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.21.4 Kyowa Hakko Kirin Recent Developments/Updates
2.22 Genkyotex
2.22.1 Genkyotex Company Profiles
2.22.2 Genkyotex Incretin-Based Drugs Product and Services
2.22.3 Genkyotex Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.22.4 Genkyotex Recent Developments/Updates
2.23 Kowa
2.23.1 Kowa Company Profiles
2.23.2 Kowa Incretin-Based Drugs Product and Services
2.23.3 Kowa Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.23.4 Kowa Recent Developments/Updates
2.24 Araim Pharmaceuticals
2.24.1 Araim Pharmaceuticals Company Profiles
2.24.2 Araim Pharmaceuticals Incretin-Based Drugs Product and Services
2.24.3 Araim Pharmaceuticals Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.24.4 Araim Pharmaceuticals Recent Developments/Updates
2.25 Amunix
2.25.1 Amunix Company Profiles
2.25.2 Amunix Incretin-Based Drugs Product and Services
2.25.3 Amunix Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.25.4 Amunix Recent Developments/Updates
2.26 Hanmi Pharmaceutical
2.26.1 Hanmi Pharmaceutical Company Profiles
2.26.2 Hanmi Pharmaceutical Incretin-Based Drugs Product and Services
2.26.3 Hanmi Pharmaceutical Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.26.4 Hanmi Pharmaceutical Recent Developments/Updates
2.27 Evoke Pharma
2.27.1 Evoke Pharma Company Profiles
2.27.2 Evoke Pharma Incretin-Based Drugs Product and Services
2.27.3 Evoke Pharma Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.27.4 Evoke Pharma Recent Developments/Updates
2.28 Ico Therapeutics
2.28.1 Ico Therapeutics Company Profiles
2.28.2 Ico Therapeutics Incretin-Based Drugs Product and Services
2.28.3 Ico Therapeutics Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.28.4 Ico Therapeutics Recent Developments/Updates
2.29 Ligand Pharmaceuticals
2.29.1 Ligand Pharmaceuticals Company Profiles
2.29.2 Ligand Pharmaceuticals Incretin-Based Drugs Product and Services
2.29.3 Ligand Pharmaceuticals Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.29.4 Ligand Pharmaceuticals Recent Developments/Updates
2.30 Merck
2.30.1 Merck Company Profiles
2.30.2 Merck Incretin-Based Drugs Product and Services
2.30.3 Merck Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.30.4 Merck Recent Developments/Updates
2.31 Ampio Pharmaceuticals
2.31.1 Ampio Pharmaceuticals Company Profiles
2.31.2 Ampio Pharmaceuticals Incretin-Based Drugs Product and Services
2.31.3 Ampio Pharmaceuticals Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.31.4 Ampio Pharmaceuticals Recent Developments/Updates
2.32 Astrazeneca
2.32.1 Astrazeneca Company Profiles
2.32.2 Astrazeneca Incretin-Based Drugs Product and Services
2.32.3 Astrazeneca Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.32.4 Astrazeneca Recent Developments/Updates
2.33 Glycadia Pharmaceuticals
2.33.1 Glycadia Pharmaceuticals Company Profiles
2.33.2 Glycadia Pharmaceuticals Incretin-Based Drugs Product and Services
2.33.3 Glycadia Pharmaceuticals Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.33.4 Glycadia Pharmaceuticals Recent Developments/Updates
2.34 Mannkind
2.34.1 Mannkind Company Profiles
2.34.2 Mannkind Incretin-Based Drugs Product and Services
2.34.3 Mannkind Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.34.4 Mannkind Recent Developments/Updates
2.35 Activx Biosciences
2.35.1 Activx Biosciences Company Profiles
2.35.2 Activx Biosciences Incretin-Based Drugs Product and Services
2.35.3 Activx Biosciences Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.35.4 Activx Biosciences Recent Developments/Updates
2.36 Coda Therapeutics
2.36.1 Coda Therapeutics Company Profiles
2.36.2 Coda Therapeutics Incretin-Based Drugs Product and Services
2.36.3 Coda Therapeutics Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.36.4 Coda Therapeutics Recent Developments/Updates
2.37 Merrion Pharmaceuticals
2.37.1 Merrion Pharmaceuticals Company Profiles
2.37.2 Merrion Pharmaceuticals Incretin-Based Drugs Product and Services
2.37.3 Merrion Pharmaceuticals Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.37.4 Merrion Pharmaceuticals Recent Developments/Updates
2.38 Conjuchem
2.38.1 Conjuchem Company Profiles
2.38.2 Conjuchem Incretin-Based Drugs Product and Services
2.38.3 Conjuchem Incretin-Based Drugs Sales, Price, Revenue ($), Gross Margin
2.38.4 Conjuchem Recent Developments/Updates

3 Competitive Environment: by Players
3.1 Global Incretin-Based Drugs Revenue ($) and Market Share of Key Players
3.2 Global Incretin-Based Drugs Sales and Market Share of Key Players
3.3 Global Incretin-Based Drugs Average Price by Players
3.4 Top 3 Incretin-Based Drugs Manufacturer Market Share in 2022
3.5 Top 5 Incretin-Based Drugs Manufacturer Market Share in 2022
3.6 Mergers & Acquisitions, Expansion

4 Industry Chain Analysis
4.1 Upstream Raw Material Suppliers of Incretin-Based Drugs Analysis
4.2 Manufacturing Cost Structure Analysis
4.2.1 Production Process Analysis
4.2.2 Manufacturing Cost Structure of Incretin-Based Drugs
4.2.3 Raw Material Cost of Incretin-Based Drugs
4.2.4 Labor Cost of Incretin-Based Drugs
4.3 Incretin-Based Drugs Industrial Chain Analysis
4.4 Major Distributors by Region
4.5 Customer Analysis

5 Incretin-Based Drugs Market Dynamic and Trends, Marketing Strategy Analysis
5.1 Drivers
5.2 Restraints
5.3 Opportunities
5.4 Challenges
5.5 Industry Development Trends under Global Inflation
5.6 Impact of Russia and Ukraine War
5.7 Industry News and Policies by Regions
5.7.1 Incretin-Based Drugs Industry News
5.7.2 Incretin-Based Drugs Industry Policies
5.8 Porters Five Forces Analysis
5.8.1 Threat of New Entrants
5.8.2 Bargaining Power of Suppliers
5.8.3 Bargaining Power of Buyers
5.8.4 Threat of Substitutes
5.8.5 Competitive Rivalry
5.9 Marketing Channel
5.9.1 Direct Marketing
5.9.2 Indirect Marketing
5.9.3 Marketing Channel Development Trend

6 Global Incretin-Based Drugs Market Segment by Type (2018-2023)
6.1 Global Incretin-Based Drugs Revenue ($) by Type (2018-2023)
6.2 Global Incretin-Based Drugs Sales by Type (2018-2023)
6.3 Global Incretin-Based Drugs Price by Type (2018-2023)
6.4 Global Incretin-Based Drugs Sales, Revenue ($) and Growth Rate by Type (2018-2023)
6.4.1 Global Incretin-Based Drugs Sales, Revenue ($) and Growth Rate of Glucagon-like peptide-1 receptor (GLP-1) agonists (2018-2023)
6.4.2 Global Incretin-Based Drugs Sales, Revenue ($) and Growth Rate of Dipeptidyl Peptidase-4 (DPP-4) inhibitors (2018-2023)

7 Global Incretin-Based Drugs Market Segment by Application (2018-2023)
7.1 Global Incretin-Based Drugs Revenue ($) by Application (2018-2023)
7.2 Global Incretin-Based Drugs Sales by Application (2018-2023)
7.3 Global Incretin-Based Drugs Sales and Growth Rate by Application (2018-2023)
7.3.1 Global Incretin-Based Drugs Sale, Revenue ($) and Growth Rate of Oral Drugs (2018-2023)
7.3.2 Global Incretin-Based Drugs Sale, Revenue ($) and Growth Rate of Injectable Drugs (2018-2023)

8 Global Incretin-Based Drugs Market Segment by Region (2018-2023)
8.1 Global Incretin-Based Drugs Sales and Market Share, Region Wise (2018-2023)
8.2 Global Incretin-Based Drugs Revenue ($) and Market Share, Region Wise (2018-2023)
8.3 Global Incretin-Based Drugs Sales, Revenue ($), Price and Gross Margin (2018-2023)
8.4 United States Incretin-Based Drugs Sales, Revenue ($), Price and Gross Margin (2018-2023)
8.4.1 United States Incretin-Based Drugs SWOT Analysis
8.5 Europe Incretin-Based Drugs Sales, Revenue ($), Price and Gross Margin (2018-2023)
8.5.1 Europe Incretin-Based Drugs SWOT Analysis
8.6 China Incretin-Based Drugs Sales, Revenue ($), Price and Gross Margin (2018-2023)
8.6.1 China Incretin-Based Drugs SWOT Analysis
8.7 Japan Incretin-Based Drugs Sales, Revenue ($), Price and Gross Margin (2018-2023)
8.7.1 Japan Incretin-Based Drugs SWOT Analysis
8.8 India Incretin-Based Drugs Sales, Revenue ($), Price and Gross Margin (2018-2023)
8.8.1 India Incretin-Based Drugs SWOT Analysis
8.9 Southeast Asia Incretin-Based Drugs Sales, Revenue ($), Price and Gross Margin (2018-2023)
8.9.1 Southeast Asia Incretin-Based Drugs SWOT Analysis
8.10 Latin America Incretin-Based Drugs Sales, Revenue ($), Price and Gross Margin (2018-2023)
8.10.1 Latin America Incretin-Based Drugs SWOT Analysis
8.11 Middle East and Africa Incretin-Based Drugs Sales, Revenue ($), Price and Gross Margin (2018-2023)
8.11.1 Middle East and Africa Incretin-Based Drugs SWOT Analysis

9 Global Incretin-Based Drugs Market Forecast Segment by Type
9.1 Global Incretin-Based Drugs Revenue ($) and Sales Forecast by Type (2023-2028)
9.1.1 Global Incretin-Based Drugs Revenue ($) Forecast by Type (2023-2028)
9.1.2 Global Incretin-Based Drugs Sales Forecast by Type (2023-2028)
9.1.3 Glucagon-like peptide-1 receptor (GLP-1) agonists Market Revenue ($) and Sales Forecast (2023-2028)
9.1.4 Dipeptidyl Peptidase-4 (DPP-4) inhibitors Market Revenue ($) and Sales Forecast (2023-2028)

10 Global Incretin-Based Drugs Market Forecast Segment by Application
10.1 Global Incretin-Based Drugs Revenue ($) and Sales Forecast by Application (2023-2028)
10.1.1 Global Incretin-Based Drugs Revenue ($) Forecast by Application (2023-2028)
10.1.2 Global Incretin-Based Drugs Sales Forecast by Application (2023-2028)
10.1.3 Oral Drugs Market Revenue ($) and Sales Forecast (2023-2028)
10.1.4 Injectable Drugs Market Revenue ($) and Sales Forecast (2023-2028)

11 Global Incretin-Based Drugs Market Forecast Segment by Region
11.1 Global Incretin-Based Drugs Revenue ($) and Sales Forecast by Region (2023-2028)
11.1.1 Global Incretin-Based Drugs Sales Forecast by Region (2023-2028)
11.1.2 Global Incretin-Based Drugs Revenue ($) Forecast by Region (2023-2028)
11.2 North America Market Revenue ($) and Growth Rate Forecast (2023-2028)
11.3 Europe Market Revenue ($) and Growth Rate Forecast (2023-2028)
11.4 China Market Revenue ($) and Growth Rate Forecast (2023-2028)
11.5 Japan Market Revenue ($) and Growth Rate Forecast (2023-2028)
11.6 India Market Revenue ($) and Growth Rate Forecast (2023-2028)
11.7 Southeast Asia Market Revenue ($) and Growth Rate Forecast (2023-2028)
11.8 Latin America Market Revenue ($) and Growth Rate Forecast (2023-2028)
11.9 Middle East and Africa Market Revenue ($) and Growth Rate Forecast (2023-2028)

12 Appendix
12.1 Methodology
12.2 Research Data Source
12.2.1 Secondary Data
12.2.2 Primary Data
12.2.3 Market Size Estimation
12.2.4 Legal Disclaimer